Obesity in children, especially at a young age, can have detrimental long-term effects on their health and wellbeing. The phase IIIa SCALE Kids trial, led by Claudia Fox, MD, evaluated the efficacy of liraglutide (Saxenda) in reducing BMI in children aged 6 to Study Findings The findings from the SCALE Kids trial demonstrated that children
Health
The recent analysis of two phase III trials exploring the use of perioperative nivolumab in non-small cell lung cancer (NSCLC) patients post-surgery has shown promising results. The study conducted by Patrick Forde, MD, and colleagues at Johns Hopkins Medicine in Baltimore demonstrated a significant reduction in the risk of disease recurrence or death among patients
The link between chronic obstructive pulmonary disease (COPD) and asthma and smoking is well established. However, a recent multicenter trial from Turkey has shown that immediately linking patients who smoke to a smoking cessation clinic can significantly improve quit rates. This trial, conducted by Dilek Karadogan, MD, at Recep Tayyip Erdoğan University, revealed that patients
A hospitalized patient in Missouri recently contracted bird flu without any known contact with dairy cows or other animals connected to the current outbreak. This marks the 14th case of bird flu in the U.S. since March, with one additional case reported in 2022. Risk to the General Public Despite the rising number of bird
The recent incident involving the No. 1-ranked tennis player, Jannik Sinner, sheds light on the pervasive issue of doping in sports. Sinner failed two drug tests in March due to the presence of the banned anabolic steroid clostebol in an over-the-counter spray he used. The spray, known as Trofodermin, is readily available in Italy without
The tragic news of Ugandan Olympic marathon runner Rebecca Cheptegei’s death at the hands of her boyfriend is not only heart-wrenching but also raises serious concerns about domestic violence and gender-based violence in sports. The fact that Cheptegei’s life was taken in such a brutal manner highlights the urgent need for more support and resources
A recent study conducted by researchers led by Diya Surie, MD, from the CDC in Atlanta, revealed promising results regarding the effectiveness of respiratory syncytial virus (RSV) vaccination in adults aged 60 and over. The study, published in JAMA, reported a vaccine effectiveness of 75% against RSV-associated hospitalization in older adults from October 2023 to
In a recent study conducted by researchers in Spain, it was found that patients with inflammatory arthritis who were prescribed biosimilar versions of etanercept or adalimumab were more likely to continue their treatment compared to those using the originator products. The discontinuation rates over a 2 to 3-year follow-up period were significantly lower for patients
The REC-CAGEFREE I randomized trial has shed light on the efficacy of drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses. The study revealed that DCB, when combined with the rescue use of drug-eluting stents (DES), resulted in a significantly higher composite 24-month rate of cardiovascular death, target vessel myocardial
Recent findings from the EPIC-CAD trial have shed new light on the management of atrial fibrillation (Afib) in patients with stable coronary artery disease (CAD). The study, presented at the European Society of Cardiology (ESC) meeting and simultaneously published in the New England Journal of Medicine, compared the efficacy of edoxaban monotherapy with dual antithrombotic